BioCentury This Week

BioCentury This Week

Por: BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
352 episodios disponibles

Latest episodes of the podcast BioCentury This Week

Mostrando página 11 de 18

Ep. 145 - What's Next for BIO, Plus: Pfizer, GSK 07/11/2022
Ep. 144 - Alnylam's IRA Pause, Plus Argenx & Accumulus 31/10/2022
Ep. 143 - East-West Summit Preview 28/10/2022
Ep. 142 - Lundbeck, Biogen, Biden & Biomanufacturing, Nora Volkow 24/10/2022
Ep. 141 - Neoantigen Vaccines, Drug Pricing, U.S.-China & U.K. Turmoil 17/10/2022
Ep. 140 - Turbulence at BIO, Plus 4Q Preview & the Distillery 10/10/2022
Ep. 139 - Wins in Neurodegeneration, U.S.-China & Life Science Cares 03/10/2022
Ep. 138 - FDA User Fee Endgame, East-West Summit & Biogen 26/09/2022
Ep. 137 - Intellia's Data, IRA's Orphan Impact, CFIUS Order 19/09/2022
Ep. 136 - IRA, KRAS & ESMO 12/09/2022
Ep 135 Pt. 5 - A Portrait of Biopharma's New Leaders 02/09/2022
Ep 135 Pt. 4 - Filling Biopharma's Talent Pipeline 01/09/2022
Ep 135 Pt. 3 - Rising Leaders & the VC View on Talent 31/08/2022
Ep 135 Pt. 2 - CEOs in the Spotlight. Plus: Women Leaders, DEI 30/08/2022
Ep 135 Pt. 1 - Back to School 2022 Overview 29/08/2022
Ep. 134 - Preclinical Deal Making, Bluebird's Approval & Epigenome Editing 22/08/2022
Ep. 133 - Financing Thaw? Plus: Protein Design & China Audits 15/08/2022
Ep. 132 - M&A & Data: recipe for a rebound? 08/08/2022
Ep. 131 - Seagen, New Modalities & Structure 01/08/2022
Ep. 130 - Steady as a Roche. Plus: Washington Turbulence 25/07/2022
« Primera ‹ Anterior 1 ... 9 10 11 12 13 ... 18 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA